Chelation Treatment for Autism Spectrum Disorders: A Systematic Review.
暂无分享,去创建一个
Tonya N. Davis | M. O'Reilly | Soyeon Kang | R. Lang | M. Rispoli | J. Sigafoos | G. Lancioni | Daelynn Copeland | S. Attai | Austin Mulloy | Mandy Rispoli
[1] N L Smith,et al. The certainty of judgments in health evaluations. , 1981, Evaluation and program planning.
[2] D. Moel,et al. Reversible nephrotoxic reactions to a combined 2,3-dimercapto-1-propanol and calcium disodium ethylenediaminetetraacetic acid regimen in asymptomatic children with elevated blood lead levels. , 1982, Pediatrics.
[3] D. Bailey,et al. Evaluating Programme Impact: Levels of Certainty , 1991 .
[4] T. Eppright,et al. Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship. , 1996, Missouri medicine.
[5] Eppright Td,et al. Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship. , 1996 .
[6] A. Wakefield,et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. , 1998, Lancet.
[7] A. Sabrá,et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children , 1998, The Lancet.
[8] Richard Simpson,et al. Interventions for Children and Youth with Autism , 1998 .
[9] Larry J. Anderson,et al. Morbidity and Mortality Weekly Report , 2002 .
[10] Lorna Wing,et al. The epidemiology of autistic spectrum disorders: is the prevalence rising? , 2002, Mental retardation and developmental disabilities research reviews.
[11] B. Schwartz,et al. Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data , 2004, Pediatrics.
[12] R. Jacobson. Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine – A systematic review of current epidemiological evidence , 2004 .
[13] J. Risher,et al. Mercury exposure: evaluation and intervention the inappropriate use of chelating agents in the diagnosis and treatment of putative mercury poisoning. , 2005, Neurotoxicology.
[14] B. Schwartz,et al. Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data , 2005, Pediatrics.
[15] Richard D. Leiker,et al. Deaths Resulting From Hypocalcemia After Administration of Edetate Disodium: 2003-2005 , 2006, Pediatrics.
[16] Lawrence Rosen,et al. Parental Perceptions and Use of Complementary and Alternative Medicine Practices for Children with Autistic Spectrum Disorders in Private Practice , 2006, Journal of developmental and behavioral pediatrics : JDBP.
[17] D. Geier,et al. A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders. , 2006, Neuro endocrinology letters.
[18] A. Doja,et al. Immunizations and Autism: A Review of the Literature , 2006, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[19] Jeff Sigafoos,et al. Internet survey of treatments used by parents of children with autism. , 2006, Research in developmental disabilities.
[20] Deaths associated with hypocalcemia from chelation therapy--Texas, Pennsylvania, and Oregon, 2003-2005. , 2006, MMWR. Morbidity and mortality weekly report.
[21] M. Strawderman,et al. Succimer Chelation Improves Learning, Attention, and Arousal Regulation in Lead-Exposed Rats but Produces Lasting Cognitive Impairment in the Absence of Lead Exposure , 2006, Environmental health perspectives.
[22] L. Curtis,et al. A comprehensive approach to treating autism and attention-deficit hyperactivity disorder: a prepilot study. , 2007, Journal of alternative and complementary medicine.
[23] M. Mitka. Chelation therapy trials halted. , 2008, Journal of the American Medical Association (JAMA).
[24] Andrea Hensley,et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A - Medical results , 2009, BMC clinical pharmacology.
[25] Andrea Hensley,et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B - Behavioral results , 2009, BMC clinical pharmacology.
[26] M. Ireland,et al. Complementary Alternative Medicine for Children with Autism: A Physician Survey , 2009, Journal of autism and developmental disorders.
[27] Andres F Zuluaga,et al. Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics , 2009, BMC clinical pharmacology.
[28] Hatice Günayer Şenel. Parents’ Views and Experiences About Complementary and Alternative Medicine Treatments for Their Children with Autistic Spectrum Disorder , 2010, Journal of autism and developmental disorders.
[29] M. O'Reilly,et al. Gluten-free and casein-free diets in the treatment of autism spectrum disorders: a systematic review , 2010 .
[30] Lora D. Delwiche,et al. Blood Mercury Concentrations in CHARGE Study Children with and without Autism , 2009, Environmental health perspectives.
[31] T. Lancet,et al. Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children , 2010, The Lancet.
[32] J. Baio. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. , 2012, Morbidity and mortality weekly report. Surveillance summaries.
[33] S. Edelson,et al. Autism Treatment Evaluation Checklist , 2012 .
[34] Intervention and Treatment , 2018, False Messengers.